Powering the Next Wave of Medicine
The Gene Partnership is a transformative new initiative that promises to unravel the root causes of diseases like autism, asthma, heart disease, and other complex conditions. The secrets of our genetic code, in combination with environmental factors, define who will suffer with common and complex diseases and inform the development of highly effective personalized therapies. The key is partnering with patients to unlock the mysteries of the human genome. The Gene Partnership’s world-renowned researchers from Children’s Hospital Boston and Harvard Medical School are leading the way with the audacious yet simple goal of identifying children who will get a disease and stopping it before it strikes. In fact, diseases usually seen in adulthood are influenced by the genetic make-up an individual is born with and the exposures they endure in early life. Therefore, the Gene Partnership empowers research and therapeutic solutions not only for childhood diseases but adult diseases as well.
The team at the Gene Partnership has created a singularly unique infrastructure to power tomorrow’s medicine. The Gene Partnership, or TGP, is a cutting-edge research initiative that combines the innovation of genomic research and information technology to create the richest longitudinal knowledge base of genetic and clinical pediatric data in the world. The power of this large amount of data will allow us to understand the basis of these “complex genetic” conditions once and for all.
The Gene Partnership was built to provide a foundation for:
- Developing new ways to diagnose diseases early – often before any symptoms – and treat them effectively with knowledge-based therapies
- Accelerating the time to market for these new diagnostics and drugs so patients benefit sooner
- Monitoring drugs that are on the market for safety, and helping to improve them
- Personalizing therapies to a specific individual to improve outcomes, reduce or eliminate side effects, and reduce waste and time loss associated with ineffective therapies – reducing medical costs (both to individuals and society) through more effective, targeted treatment and prevention
- Optimizing business processes in care delivery through secondary uses of data to make healthcare better and sustainable
- Informing public policy around issues of privacy and patients’ right to know in the genomic era
- Powering the next wave of collaborative research with quicker bench-to-bedside transitions, and doing so with full participation and protection of research participants
In short, TGP is providing the global scientific community with an unsurpassed resource for research and care delivery that will save and improve lives by unraveling the complex links between genes, environment, and disease in children and in adults.
